Methods and Compositions for Improving Cognitive Function

This invention relates to treating age-related cognitive impairment. This invention in particular relates to the use of inhibitors of synaptic vesicle protein 2A (SV2A), such as levetiracetam, seletracetam, and brivaracetam, in improving cognitive function in subjects that exhibit age-related cognitive impairment or are at risk thereof, including, without limitation, subjects having or at risk for Mild Cognitive Impairment (MCI), Age-related Cognitive Decline (ARCD) or Age-Associated Memory Impairment (AAMI).

Attached files:
CA 2740610.jpg

Patents:
CA 2,740,610

Inventor(s): GALLAGHER MICHELA [US]; HABERMAN REBECCA [US]; KOH MING TENG [US]

Type of Offer: Licensing

Contact Patent Owner or Broker


Next Patent »
« More Medical Patents

Share on      

CrowdSell Your Patent